XNAS
LFWD
Market cap385mUSD
Oct 08, Last price
6.43USD
1D
-1.08%
1Q
-23.32%
Jan 2017
-99.89%
IPO
-99.99%
Name
Rewalk Robotics Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ReWalk Robotics Ltd., an Israeli medical technology firm, was founded in 2001 and is headquartered in Yokneam Ilit. The company specializes in the creation and market introduction of robotic exoskeletons. These advanced devices are engineered to support individuals confronting mobility challenges or various other medical conditions across major global markets including the United States, Europe, the Asia-Pacific region, and Africa. Its product line features the ReWalk Personal and ReWalk Rehabilitation systems, designed for daily assistance for paraplegic individuals with spinal cord injuries, enabling their use both at home and within their communities. For clinical rehabilitation of stroke patients with lower limb disabilities, ReStore provides a soft exo-suit. Additionally, ReWalk offers the MyoCycle and MediTouch tutor, biofeedback tools facilitating movement therapy in either home or clinical environments. ReWalk Robotics distributes its innovative solutions directly to diverse clients, including third-party payers, rehabilitation centers and other institutions, and individual users. It also leverages third-party distributors to broaden its reach. The company operated previously under the name Argo Medical Technologies Ltd.
Key people
Robert Marshall
Independent Chairman of the Board · since 2026
Chief Financial Officer · since 2022
Almog Adar
Chief Financial Officer · since 2025
Jeannine Lynch
Vice President of Market Access and Strategy · since 2021
Mark Grant
President, Chief Executive Officer, Director · since 2025
Chief Executive Officer, Director · since 2012
Director · since 2022
Michael Swinford
Director · since 2024
John Poduska
Independent Director · since 2014
Mike Swinford
Independent Director · since 2024
Headquarters & legal address
3 Hatnufa st. 6th fl., P.O. Box 161
Yokneam, Z 2069203
IL
Yokneam, Z 2069203
IL
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||